Poland· PL-100206170
Efient
A prasugrel product containing prasugrelum, registered in Poland by Substipharm. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Prasugrel is registered in 19 of 19 countries.
Countries holding a registration under ATC B01AC22 (prasugrel), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Prasugrel · ATC B01AC22
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of prasugrel costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.67 in France to $3.02 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Prasugrel · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.02
- IT Italy$1.61
- ES Spain$1.36
- FR France$0.67
The record
At a glance
URPL (Poland)- Active substance
- Prasugrelum
- Manufacturer
- Substipharm
- Country
- Poland (PL)
- ATC code
- B01AC22
- ATC class
- Prasugrel
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909990893607
- gtin03665140000326
- gtin05909990686650
- gtin05909990686667
- gtin05909990686605
- gtin05909990686636
- gtin05909990686643
- gtin05909990686599
- gtin05909990686629
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
219 interactions on record for prasugrel.
Graded by severity as the source publishes them — 91 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Prasugrel · interactions on record
219 records
- 91 severe
- 89 moderate
- 19 minor
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Antithrombin IIIB01AB02severe
- DalteparinB01AB04severe
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Prasugrel in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEFIENTSubstipharm, Paris
- SpainEFIENT 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULASubstipharm
- United StatesPrasugrelAccord Healthcare Inc.
- SwedenEfient 5 mg Filmdragerad tablettSubstipharm
- IcelandEfientSubstipharm
- SwitzerlandEfient
- NetherlandsEfient 5 mg filmomhulde tablettenSubstipharm
- IrelandEfient 5 mg Film-coated tabletSubstipharm
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Prasugrel Hcs, Prasugrel Ratiopharm
- Belgium · Prasugrel Krka
- Bulgaria · Eлискардиа, Бевим
- Czechia · Eliskardia
- Germany · Prafsia, Prasillt
- Denmark · Prafsia, Prasugrel Eql Pharma
- Estonia · Eliskardia, Prasugrel Alembic
- Spain · Prafsia, Prasugrel Combix
- France · Prafsia, Prasugrel Arrow
- United Kingdom (Northern Ireland) · Prasugrel, Prasugrel Accord
- Greece · Prafsia, Prasugrel Vocate
- Croatia · Eliskardia, Prasugrel Pliva
- Hungary · Bewim, Eliskardia
- Ireland · Prasugrel Accord, Prasugrel Krka
- Iceland · Efient, Prasugrel G.L. Pharma
- Italy · Drullub, Prafsia
- Liechtenstein · Efient, Prasugrel Viatris
- Lithuania · Eliskardia
- Malta · Prasugrel Vocate
- Netherlands · Prasugrel Ratiopharm, Prasugrel Teva
- Norway · Efient, Prasugrel Eql Pharma
- Portugal · Prasugrel Pentafarma, Prasugrel Tecnigen
- Romania · Eliskardia
- Sweden · Prasugrel Eql Pharma, Prasugrel G.L. Pharma
- Slovenia · Eliskardia, Tosynal
- Slovakia · Bewim, Sigrada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8171062c-c5eb-47f9-af27-34a534101981 GET /v1/drugs/8171062c-c5eb-47f9-af27-34a534101981?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909990686650 ¦ Rp ¦ EU/1/08/503/006 ¦ 21749\n90 tabl. w blistrze perforowanym\n05909990686667 ¦ Rp ¦ EU/1/08/503/007 ¦ 22600\n98 tabl. w blistrze\n05909990686605 ¦ Rp ¦ EU/1/08/503/002 ¦ 48874\n28 tabl.\n05909990686636 ¦ Rp ¦ EU/1/08/503/004 ¦ 48876\n56 tabl.\n05909990686643 ¦ Rp ¦ EU/1/08/503/005 ¦ 48877\n84 tabl.\n05909990686599 ¦ Rp ¦ EU/1/08/503/001 ¦ 68604\n14 tabl.\n05909990686629 ¦ Rp ¦ EU/1/08/503/003 ¦ 68605\n30 tabl. w blistrze perforowanym\n05909990893607 ¦ Rp ¦ EU/1/08/503/015 ¦ 68606\n30 tabl. w blistrze\n03665140000326 ¦ Rp ¦ EU/1/08/503/002 ¦ 147025\n28 tabl.",
"substance": "Prasugrelum 5 mg",
"common_name": "Prasugrelum",
"pl_product_id": "100206170",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about prasugrel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.